Nav: Home

Largest ever brain cancer study reveals new secrets to inherited risk

March 27, 2017

Scientists have uncovered a treasure trove of information about the genetic causes of brain cancer in the largest ever study of the disease.

Their research has revealed 13 new genetic errors associated with an increased risk of developing glioma -- the most common form of brain cancer.

One of the genetic changes increases risk by as much as a third and the others by at least 15 per cent each. That means the new information could be used to pick out some people at substantially increased risk of developing the disease.

Scientists at The Institute of Cancer Research, London, along with colleagues in Europe and the US, led the international study of more than 30,000 people with and without glioma. Their aim was to find sequence changes in DNA among these people passed on from their parents that increase risk of the disease.

Gliomas account for around 40 per cent of all brain tumours, there is currently no reliable way of detecting the disease early and current treatments are not particularly effective.

The new research reveals a wealth of new information about what predisposes a person to gliomas, and could in future allow doctors to monitor those most at risk, diagnose the disease earlier, and lead to the discovery of badly needed new drugs.

The study is published today (Monday) in the prestigious journal Nature Genetics, and was funded by the National Institutes for Health in the US, with additional support from UK charities -- Cancer Research UK, Wellcome and the DJ Fielding Medical Research Trust.

The researchers carried out two new genome-wide studies and combined the results with six previous studies in a 'meta-analysis' -- involving in total 12,496 cases of glioma and 18,190 people without.

The size of the study meant it was able to detect 13 previously undiscovered genetic changes that increased the risk of glioma. These were found to affect a variety of cell functions, including nerve cell division, DNA repair, cell cycle control, protein production and inflammation.

Scientists at The Institute of Cancer Research (ICR) and their colleagues found that different sets of genes influence a person's risk of developing the two subtypes of glioma - glioblastoma and non-glioblastoma.

For example, one of the DNA changes influencing activity of the gene HEATR3 increases the risk of glioblastoma -- a particularly aggressive type of glioma with an average survival of only 10-15 months after diagnosis -- by 18 per cent. But it has a much smaller effect on the risk of developing non-glioblastoma.

As well as identifying new genetic changes, the team generated even stronger evidence for the roles of DNA errors in the genes they previously identified as being associated with glioma and other cancers -- including p53, EGFR, and the genes TERT and RTEL1 which function to protect the ends of chromosomes.

The study doubles the total number of genetic changes associated with risk of glioma -- taking it up to 26.

Study co-leader Professor Richard Houlston, Professor of Molecular and Population Genetics at The Institute of Cancer Research, London, said:

"It's been exciting to have been involved in such a gigantic study including cases of brain cancer from all over the world. We've uncovered a treasure trove of new information about the genetic causes of glioma brain cancers.

"Understanding the genetics of glioma in such detail allows us to start thinking about ways of identifying people at high inherited risk, and will open up a search for new treatments that exploit our new knowledge of the biology of the disease.

"The changes in the way we think about glioma could be quite fundamental. So for example, what we thought of as two related sub-types of the disease turn out to have quite different genetic causes which may require different approaches to treatment."

Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:

"The genetics of glioma had been poorly understood, but this huge and excellent new study at a stroke gives us the same kind of knowledge of the disease as we have with other, more intensely studied cancers. It's a significant step forward which I believe will have clear implications for our ability to identify people at high risk, and to treat them."
-end-
Notes to editors

For more information please contact Claire Hastings on 020 7153 5380 or claire.hastings@icr.ac.uk. For enquiries out of hours, please call 07595 963 613.

The Institute of Cancer Research, London, is one of the world's most influential cancer research organisations.

Scientists and clinicians at The Institute of Cancer Research (ICR) are working every day to make a real impact on cancer patients' lives. Through its unique partnership with The Royal Marsden NHS Foundation Trust and 'bench-to-bedside' approach, the ICR is able to create and deliver results in a way that other institutions cannot. Together the two organisations are rated in the top four centres for cancer research and treatment globally.

The ICR has an outstanding record of achievement dating back more than 100 years. It provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today it is a world leader at identifying cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

A college of the University of London, the ICR is the UK's top-ranked academic institution for research quality, and provides postgraduate higher education of international distinction. It has charitable status and relies on support from partner organisations, charities and the general public.

The ICR's mission is to make the discoveries that defeat cancer. For more information visit http://www.icr.ac.uk

Institute of Cancer Research

Related Dna Articles:

A new spin on DNA
For decades, researchers have chased ways to study biological machines.
From face to DNA: New method aims to improve match between DNA sample and face database
Predicting what someone's face looks like based on a DNA sample remains a hard nut to crack for science.
Self-healing DNA nanostructures
DNA assembled into nanostructures such as tubes and origami-inspired shapes could someday find applications ranging from DNA computers to nanomedicine.
DNA design that anyone can do
Researchers at MIT and Arizona State University have designed a computer program that allows users to translate any free-form drawing into a two-dimensional, nanoscale structure made of DNA.
DNA find
A Queensland University of Technology-led collaboration with University of Adelaide reveals that Australia's pint-sized banded hare-wallaby is the closest living relative of the giant short-faced kangaroos which roamed the continent for millions of years, but died out about 40,000 years ago.
DNA structure impacts rate and accuracy of DNA synthesis
DNA sequences with the potential to form unusual conformations, which are frequently associated with cancer and neurological diseases, can in fact slow down or speed up the DNA synthesis process and cause more or fewer sequencing errors.
Changes in mitochondrial DNA control how nuclear DNA mutations are expressed in cardiomyopathy
Differences in the DNA within the mitochondria, the energy-producing structures within cells, can determine the severity and progression of heart disease caused by a nuclear DNA mutation.
Switching DNA and RNA on and off
DNA and RNA are naturally polarised molecules. Scientists believe that these molecules have an in-built polarity that can be reoriented or reversed fully or in part under an electric field.
New DNA synthesis technique promises rapid, high-fidelity DNA printing
Today, DNA is synthesized as an organic chemist would, using toxic chemicals and error-prone steps that limit accuracy and thus length to about 200 base pairs.
The changing shape of DNA
The shape of DNA can be changed with a range of triggers including copper and oxygen - according to new research from the University of East Anglia.
More Dna News and Dna Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.